Sjögren’s disease can be difficult, but going through it alone can be even more challenging. It’s time to be seen.
At the Global Healthy Living Foundation, we are committed to connecting you with opportunities to participate in clinical research that has the potential to improve treatment outcomes for patients like you in the future. The DAFFODIL trial is evaluating an investigational medicine for adults with Sjörgen’s disease.
YOU MAY QUALIFY FOR THIS TRIAL IF YOU:
About the DAFFODIL Trial
The DAFFODIL Trial is evaluating the efficacy and safety of an investigational medicine for moderate to severe Sjögren’s disease.
The trial involves up to 30 visits over the course of up to about 3 years. Visits will take place once a week for the first month and about once a month after that. Participants are randomly assigned to 1 of 2 groups and will receive either the investigational medicine or a placebo, administered as an injection under the skin (subcutaneous). A placebo is a substance that looks like the investigational medicine but contains no active ingredients.
For every 5 participants who enroll, 3 will be assigned to the group receiving the investigational medicine. After the first 48 weeks of the trials, eligible participants can move into a long-term extension period, during which all participants will receive the investigational medicine for 96 weeks. Participants may be able to continue their current Sjögren’s disease-related medications. The trial doctor or staff will provide more information about this.
You can play a role in helping researchers evaluate investigational medications for Sjögren’s’ disease by participating in this trial. Participants may be reimbursed for trial-required travel and expenses.
Stay Informed on Upcoming Clinical Trial Opportunities
Even if you’re not ready to be a part of a clinical trial, or you aren’t eligible for this one, you can still stay informed on upcoming clinical trial opportunities by joining our email list.
